Mugisha Paul, Gründemann Dirk, Schömig Edgar, Uhlén Staffan
Department of Physiology, Uppsala University, Box 572 BioMedical Centre, 751 23 Uppsala, Sweden.
Naunyn Schmiedebergs Arch Pharmacol. 2002 May;365(5):335-40. doi: 10.1007/s00210-002-0536-z. Epub 2002 Apr 5.
[(3)H]Prazosin bound to alpha(1A)- and alpha(1B)-adrenoceptors, as well as to a cimetidine-sensitive non-alpha(1)-adrenoceptor binding site in rat kidney membranes. An experimental design is presented where the alpha(1)-adrenoceptors are selectively exposed by blocking the non-alpha(1) binding site with 60 microM cimetidine. Conversely, the non-alpha(1) binding site can be selectively exposed by blocking the alpha(1)-adrenoceptors with 600 nM metitepine. The identity of the non-alpha(1) binding site for [(3)H]prazosin in the rat kidney, herein pharmacologically characterized by 33 competing substances, is still unknown.